HORMONE therapyDRUG therapy for asthmaMORTALITY risk factorsADRENERGIC beta agonistsADRENOCORTICAL hormonesBIOPSYMEDICAL protocolsNITRIC oxideDISEASE managementDISEASE remissionThe article presents arguments supporting the recommendation of the British Thoracic Society (BTS) to use inhaled costicosteroids (ICS) as...
As-needed anti-inflammatory reliever therapy for asthma management : evidence and practical considerations Over-reliance on SABA bronchodilators for rapid symptom relief is common in real life and potentially leads to an increased risk of asthma morbidity and ... A Bianco,M Contoli,FD Marco,......
Pharmacogenetic factors af‐ fecting asthma treatment response:potential implications for drug therapy[J]. Front Pharmacol,2019,10:520. (下转第 723 页) ·718· China Pharmacy 2023 Vol. 34 No. 6 中国药房 2023 年第 34 卷第 6 期 http-equiv="content-type" ...
“There are very few head-to-head trials,”Bradley E. Chipps, MD,medical director of respiratory therapy and the cystic fibrosis center at Sutter Medical Center in Sacramento, California, said during his presentation. “The dots were connected using indirect measures.” Bradley E. C...
therapybronchial hyperresponsivenesscalcium sensing receptorcalcilyticinflammationIntroduction: Asthma afflicts more than 300 million people. Contemporary mainstay therapies (inhaled corticosteroids and bronchodilators), prescribed empirically, control symptoms resulting from airways obstruction tolerably well in many ...
Furthermore, GINA 2019, for the first time, recommended against SABA-only treatment of asthma in adults or adolescents (Figure 1) [24]. Figure 1. The evolution of SABA therapy in GINA guidelines for mild asthma over the last decades. Accordingly, in Step 2, daily low dose ICS plus as...